What's New/
Latest news
- All
- Advocacy
- Experiences
- Guest Blog
- Information
- Research
- Reviews
- All
- Advocacy
- Experiences
- Guest Blog
- Information
- Research
- Reviews
Research Update on the number of people with migraine in New Zealand
In the absence of up-to-date national statistics on migraine in Aotearoa New Zealand, we rely ...
Read More
Information Medsafe approves atogepant for use in New Zealand
Medsafe has approved the migraine medication atogepant (Aquipta, also known as Qulipta) be added to ...
Read More
Advocacy Shades for Migraine 2024
Shades for Migraine 2024 is fast approaching, so grab your sunnies, get creative and help ...
Read More
Advocacy Modern migraine medications added to Pharmac’s Options for Investment list
Funding of galcanezumab (Emgality), erenumab (Aimovig) and atogepant (Aquipta) progressed one step closer this week, ...
Read More
Advocacy Our partnership with the Neurological Alliance
Migraine Foundation Aotearoa New Zealand is a member of the Neurological Alliance, a collection of (currently) ...
Read More
Research Multiple barriers to health care for migraine disease
Press release People with migraine disease experience similar barriers to health care as patients with ...
Read More
Advocacy Inaugural NZ Medicine Access Summit
The first-ever national event to discuss New Zealand’s woeful access to modern medicines was held ...
Read More
Information Migraine or ‘sinus headache’?
The symptoms of migraine disease are commonly mistaken for those of another condition. This means ...
Read More
Research Survey results published in NZ Medical Journal
We published our first paper from the inaugural Migraine in Aotearoa New Zealand Survey in ...
Read More
ExperiencesGuest Blog All in my head
In this guest blog, we share a reflection on living with migraine from Elizabeth Heritage. ...
Read More
Guest BlogResearch The reality of healthcare for migraine in New Zealand
In this guest blog, medical student Blair McInnarney shares what he has learnt about migraine ...
Read More
Advocacy Pharmac proposes to decline zolmitriptan after 17 years of waiting
Jump back to 2007. More than fifteen years ago, in 1991, sumatriptan was launched, the ...
Read More
